Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2 infection can inform subsequent protection and risk of reinfection, however large-scale representative studies are limited. Here we estimated antibody response after SARS-CoV-2 infection in the general po...
Main Authors: | Wei, J, Matthews, PC, Stoesser, N, Maddox, T, Lorenzi, L, Studley, R, Bell, JI, Newton, JN, Farrar, J, Diamond, I, Rourke, E, Howarth, A, Marsden, BD, Hoosdally, S, Jones, EY, Stuart, DI, Crook, DW, Peto, TEA, Pouwels, KB, Walker, AS, Eyre, DW |
---|---|
Other Authors: | COVID-19 Infection Survey team |
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2021
|
Similar Items
-
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
by: Eyre, DW, et al.
Published: (2021) -
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
by: Pouwels, KB, et al.
Published: (2021) -
Symptoms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity in the general population in the United Kingdom
by: Vihta, K-D, et al.
Published: (2021) -
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
by: Pritchard, E, et al.
Published: (2021) -
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
by: Wei, J, et al.
Published: (2023)